To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy

NCT01322282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy

Interventions

DRUG: Cetirizine
DRUG: Cetirizine

Sponsor

McNeil AB